Correspondence 0001104659-24-120691 from Translational Development Acquisition Corp. (TDAC, TDACU) (CIK 0001926599) (TDAC)
Translational Development Acquisition Corp. (TDAC, TDACU) (CIK 0001926599)
Date: Nov. 19, 2024 · CIK: 0001926599 · Accession: 0001104659-24-120691
AI Filing Summary & Sentiment
File numbers found in text: 333-282763
Referenced dates: November 5, 2024
Show Raw Text
CORRESP
1
filename1.htm
November 19, 2024
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
Office of Real Estate & Construction
100 F Street, N.E.
Washington, D.C. 20549
Attention:
Frank Knapp
Jennifer Monick
Ronald (Ron) E. Alper
Brigitte Lippmann
Re:
Translational Development Acquisition Corp.
Registration Statement on Form S-1
Filed October 22, 2024
File No. 333-282763
Ladies and Gentlemen:
On behalf of our client,
Translational Development Acquisition Corp. (the “Company,” “we,” “our” or “us”),
we are responding to the comments from the staff (the “Staff”) of the Securities and Exchange Commission (the “Commission”)
in your letter dated November 5, 2024 (the “Comment Letter”), with respect to the above-captioned Registration
Statement on Form S-1 (the “Registration Statement”).
For your convenience, each
of the Staff’s comments contained in the Comment Letter is duplicated below in bold and is followed by the Company’s response.
All references in this letter
to page numbers and captions (other than those in the Staff’s comments) correspond to the page numbers in the Registration
Statement on Form S-1 publicly filed with the Commission on November 20, 2024 (the “Registration Statement”),
unless otherwise noted. Defined terms used but not otherwise defined herein have the meanings ascribed to such terms in the Registration
Statement.
November 19, 2024
Page 2
Registration Statement on Form S-1 filed October 22,
2024
Cover Page
1. We
note your response to prior comment 2. Please also describe the private placement warrants
issuance to your sponsor and the price paid for the private placement warrants where you
discuss material dilution to your public shareholders.
Response:
We have revised the prospectus cover page of the Registration Statement.
General
2. We
note your response to prior comment 11. We are considering your response and may have further
comment.
Response:
We have revised the disclosure in the Registration Statement on the cover page and pages 15, 150 and 164.
3. We
note your disclosure regarding the assignment and novation agreement pursuant to which Stone
Capital Partners LLC's rights, obligations and liabilities under the previous subscription
agreement were transferred to and assumed by TDAC Partners LLC and TDAC Partners LLC became
your current sponsor. We also note that Michael B. Hoffman is the managing member and owns
100% of the economic interests in both entities. Please disclose the purpose of the assignment
and novation agreement.
Response:
We have revised the disclosure in the Registration Statement on pages 1, 21, 24, 69, 163 and 168.
* * *
November 19, 2024
Page 3
Thank you for your attention to this response. If you have any questions
related to this letter, please contact the undersigned at (212) 503-9812.
Very truly yours,
/s/ William N. Haddad
William N. Haddad
Venable LLP
cc:
Michael B. Hoffman, Translational Development Acquisition Corp.
Avanindra C. Das, Translational Development Acquisition Corp.
Arif Soto, Venable LLP
Mitchell S. Nussbaum, Loeb & Loeb LLP
David J. Levine, Loeb & Loeb LLP